Your session is about to expire
← Back to Search
Therapeutic Estradiol for Breast Cancer
Study Summary
This trial is studying how well estradiol works in treating patients with a certain type of breast cancer that has spread.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have a history of blood clotting disorders.I have had 2 or more blood clots in the last 5 years.My cancer's size or presence can be tracked with scans.Your hemoglobin level should be at least 8 grams per deciliter within 14 days before joining the study.I have gone through menopause.I am willing to have a biopsy for breast cancer markers if I haven't had one in the last year.My cancer cells show a certain level of ERbeta protein.I agree to provide a biopsy sample for testing.I have not had a blood clot in my veins or lungs in the last year.I do not have any serious ongoing illnesses, including heart problems or uncontrolled high blood pressure.I am willing to stop taking certain medications that affect how my body processes drugs.Your creatinine levels are within a certain range, as tested within the last 14 days before joining the study.I am a woman aged 18 or older.I haven't had chemotherapy, immunotherapy, or other specific cancer treatments in the last 14 days.My brain metastases meet specific health criteria.Your total bilirubin level must be no more than 1.5 times the upper limit of normal within 14 days before enrolling in the study.My liver function tests are within the required range.I am fully active or restricted in physically strenuous activity but can do light work.I have not had a stroke in the last 6 months.My tumor is negative for both ER and HER2.I have had 3 or fewer chemotherapy treatments for my metastatic breast cancer.Your platelet count should be at least 75,000 per cubic millimeter within 14 days before joining the study.I have had abnormal bleeding from my uterus in the last 6 months.I have not had any cancer other than non-melanoma skin cancer in the last 3 years.I can take pills by mouth.My breast cancer is not driven by estrogen or HER2.
- Group 1: Treatment (estradiol)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there long-term risks associated with taking Therapeutic Estradiol?
"Power's team has rated the safety of Therapeutic Estradiol as a 2. This is due to it being in Phase 2 clinical trials, where there is evidence of safety but not yet efficacy."
Are participants being recruited for this clinical research at present?
"That is correct.if you visit clinicaltrials.gov, you'll see that the most recent update to this study was on 8/31/2022. The trial is seeking 38 individuals who are willing to participate at 14 different locations."
In how many different geographical areas is this trial taking place?
"Presently, this trial is being conducted in 14 different centres. These locations include Jacksonville, Chicago and Bronx as well other surrounding areas. If you are interested in enrolling, it would be beneficial to choose the site closest to your residence to cut down on commute times."
How many people are helping to test this new medication?
"Yes, the data on clinicaltrials.gov indicates that this study is looking for participants. The trial was first posted on 8/28/2019 and was last updated on 8/31/2022. 38 patients need to be recruited from 14 different sites."
Do you know of any other times when Therapeutic Estradiol has been studied?
"Estradiol's therapeutic effects were first investigated in 1996 at the National Institutes of Health Clinical Center. To date, there have been a total of 351 completed trials worldwide. There are currently 52 live clinical trials, with a significant portion taking place in Jacksonville, Florida."
What are the benefits of taking Therapeutic Estradiol?
"Therapeutic Estradiol is most commonly used to treat amenorrhea, or the absence of a menstrual period, in women who have not had one in the last 6 months. However, it can also be helpful for managing other conditions like hypoestrogenism, menopausal vasomotor symptoms, and breast cancer."
Share this study with friends
Copy Link
Messenger